Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment

Abdallah, Chadi G., Averill, Christopher L., Salas, Ramiro, Averill, Lynnette A., Baldwin, Philip R., Krystal, John H., Mathew, Sanjay J., Mathalon, Daniel H.·2017·Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
DOI 10.1016/j.bpsc.2017.04.006

Cited by (111)

Items 101–111 of 111

  1. Inducing a Functional-Pharmacological Coupling in the Human Brain to Achieve Improved Drug Effect
    Roy Sar-El, Gal Raz, Nitzan Lubianiker, Haggai Sharon, Talma Hendler · 2020 · Frontiers in Neuroscience
  2. Mood Disorders and Creativity
    Natalia Jaworska, Georg Northoff · 2023 · Current clinical neurology
  3. Neurobiologie der therapieresistenten Depression (TRD)
    Andreas Reif · 2022 · Springer eBooks
  4. Attenuation of severe ketamine-induced neuropsychiatric side effects by lamotrigine in a patient with treatment resistant bipolar depression: A case report
    Brian Scott Barnett, Amit Anand · 2023 · Psychiatry Research Case Reports
  5. Neural synchronization in fMRI and EEG/MEG—a methodological guide
    Georg Northoff · 2024 · Elsevier eBooks
  6. The Analgesic and Dissociative Properties of Ketamine are Separate and Correspond to Distinct Neural Mechanisms
    Noam Goldway, Talma Hendler, Itamar Jalon, Yotam Pasternak, Roy Sar-El, Dan Mirelman, Noam Sarna, Nili Green, Yara Agbaria, Haggai Sharon · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  7. Dynamic Processes Induced by Ketamine and Their Potential for Augmented Treatment Strategies in Neuropsychiatric Disorders
    Meng Li, Zümrüt Duygu Şen, Lena Vera Danyeli, Nooshin Javaheripour, Martin Walter · 2025 · Neuromethods
  8. Hyperresponsiveness to inflammatory stimulation in human neuronal-like cells from patients with inflammation-associated depression
    Susanne Schillo, Carmen Schiweck, Mareike Aichholzer, Anna Y. Yotova, T. Tsengenbayar, Sharmili Edwin Thanarajah, Andreas Reif, Florian Freudenberg · 2025 · Frontiers in Psychiatry
  9. Esketamine’s therapeutic effect on anhedonia in adolescents: a post-hoc of a randomized controlled trial
    Qianqian Wu, Weicheng Li, Zhanjie Luo, Chengyu Wang, Xiaofeng Lan, Junhao Shen, Z X Chen, Jincai Pan, Xuan Liu, Hao Zhu et al. · 2026 · BMC Psychiatry
  10. Short‐ and Midterm Analgesic Outcomes of Ketamine Versus Lidocaine Infusion in Chronic Peripheral Neuropathic Pain: A Retrospective Study
    Mevlüt Gökhan Sucu, Tuğçe Yavuz Mollavelioğlu, Ayşegül Akyüz, Nalan Çelebi · 2026 · Pain Research and Management
  11. Enzephalopathien bei psychiatrischen Erkrankungen
    Julia Reiff, Dieter F. Braus · 2026 · Springer eBooks